急速自我修復凝胶的全球市场:市场规模 - 各架桥类型,各用途,各地区展望,竞争策略,各市场区隔预测(~2032年)
市场调查报告书
商品编码
1213648

急速自我修復凝胶的全球市场:市场规模 - 各架桥类型,各用途,各地区展望,竞争策略,各市场区隔预测(~2032年)

Rapid Self-Healing Gel Market Size- By Crosslinking Type, By Application- Regional Outlook, Competitive Strategies and Segment Forecast to 2032

出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 241 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球急速自我修復凝胶的市场规模,预计至2032年达到5亿1,000万美元,以8.61%的年复合成长率成长。

由于外伤和慢性创伤增加,在预测期间内预计市场成长。再加上为了提高急速自我修復凝胶的有效性的临床试验更大量实施,预计市场扩大。

本报告提供全球急速自我修復凝胶市场相关调查,市场动态,市场变数与展望,竞争情形,各架桥类型、用途、地区的市场分析,企业简介等相关资讯。

目录

第1章 简介

  • 调查范围
  • 市场区隔分析

第2章 调查手法

  • 调查资料来源
  • 市场规模的估计
  • 资料的三角测量

第3章 摘要整理

第4章 市场动态

  • 促进因素,阻碍因素,机会,课题的分析
    • 促进因素
    • 阻碍因素
    • 机会
    • 课题
  • 全球急速自我修復凝胶市场上COVID-19的影响

第5章 市场变数与展望

  • SWOT分析
    • 优势
    • 弱点
    • 机会
    • 威胁
  • PESTEL分析
    • 政治形势
    • 经济形势
    • 社会形势
    • 技术形势
    • 环境形势
    • 法律上的形势
  • 波特的五力分析
    • 供给企业谈判力
    • 买方议价能力
    • 替代品的威胁
    • 新加入厂商的威胁
    • 竞争企业间的敌对关係
  • 热图分析

第6章 竞争情形

  • 全球急速自我修復凝胶的製造地流通,销售区域,产品类型
  • 全球急速自我修復凝胶市场的合併、收购,伙伴关係,产品销售,合作

第7章 全球急速自我修復凝胶市场:各架桥类型(2019年~2032年(100万美元))

  • 化学
  • 物理

第8章 全球急速自我修復凝胶市场:各用途(2019年~2032年(100万美元))

  • 3D印刷
  • 药物运输
  • 表面涂料
  • 组织工程
  • 创伤治疗
  • 其他

第9章 全球急速自我修復凝胶市场:各地区(2019年~2032年(100万美元))

  • 全球急速自我修復凝胶的规模、市场占有率:各地区(2019年~2025年)
  • 全球急速自我修復凝胶的规模、市场占有率:各地区(2026年~2032年)
  • 亚太地区
    • 澳洲
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他的亚太地区
  • 欧洲
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 英国
    • 其他的欧洲
  • 中东、非洲
    • 沙乌地阿拉伯王国
    • 阿拉伯联合大公国
    • 其他的中东、非洲
  • 北美
    • 加拿大
    • 墨西哥
    • 美国
  • 南美
    • 阿根廷
    • 巴西
    • 其他的南美

第10章 企业简介

  • Advanced Medical Solutions Group PLC
    • 企业概要
    • 财务展望
    • 产品概要
    • 最近的开发
  • Alliqua Biomedical
  • Axelgaard
  • Cardinal Health
  • Contura International
  • Cytogel Pharma
  • Hydromer Inc.
  • Katecho Inc.
  • R&D Medical Products Inc.
  • Scapa Healthcare

第11章 简称一览

第12章 参照链接

第13章 结论

第14章 调查范围

简介目录
Product Code: PHAR2302

Global Rapid Self-Healing Gel Market Overview

According to SPER Market Research, the Global Rapid Self-Healing Gel Market is estimated to reach USD 0.51 billion by 2032 with a CAGR of 8.61%.

A unique variety of polymer hydrogel known as rapid self-healing gel is a cross-network of polymers connected to one another by chemical or physical interactions such as hydrogen bonds, ionic interactions, and others between the unit polymers. These gels have a very high capacity for hydration, which makes them elastic, sensitive, and permeable. The three-dimensional structure of these gels can also be maintained in spite of environmental changes including mechanical and physical degradation. Researchers can use quick self-healing gels in a range of biomedical applications, such as tissue engineering, wound healing, medication delivery, cosmetology, and others, thanks to the hydrogel's ability to simulate flesh or skin. The market for quick self-healing gel is expected to grow over the course of the projection period as a result of the rise in trauma and chronic wound situations. Additionally, it is projected that the market would expand over the course of the projection period as more clinical trials are carried out to improve the effectiveness of rapid self-healing gel. Expanding R&D activities may facilitate the development of novel rapid self-healing gels, which is projected to drive the growth of the global market for these gels during the ensuing years.

Rapid Self-Healing Gel Market

Impact of COVID-19 on the Global Rapid Self-Healing Gel Market

The COVID-19 epidemic caused a drop in the market for Rapid Self-healing Gel. The world has been negatively impacted by this deadly virus, particularly North America and Europe. Companies have shut down their operations and manufacturing facilities, and the government has curtailed production activities to stop the virus from spreading further. All industries have seen a decrease in the use of Rapid Self-healing Gel as a result. However, there aren't any limits at the moment, and the virus's spread is likewise under control. The availability of raw materials needed for the production of self-healing gel during the pandemic was constrained due to the effects of the coronavirus (COVID-19) epidemic. As a result, it is anticipated that the COVID-19 pandemic will impede the market for rapid self-healing gel. Consequently, businesses are growing and fostering healthy competition for the Rapid Self-healing Gel market.

Scope of the Report

Report Metric Details:

  • Market size available for years: 2019-2032
  • Base year considered: 2021
  • Forecast period: 2022-2032
  • Segments covered: By Crosslinking Type, By Application
  • Regions covered: Asia Pacific, Europe, Middle East and Africa, North America, Latin America
  • Companies Covered: Advanced Medical Solutions Group PLC, Alliqua Biomedical, Axelgaard, Cardinal Health, Contura International, Cytogel Pharma, Hydromer Inc., Katecho Inc., R&D Medical Products Inc., Scapa Healthcare

Global Rapid Self-Healing Gel Market Segmentation:

  • By Crosslinking Type: Based on the Crosslinking Type, Global Rapid Self-Healing Gel Market is segmented as; Chemical, Physical.
  • By Application: Based on the Application, Global Rapid Self-Healing Gel Market is segmented as; 3D Printing, Drug Delivery, Surface Coating, Tissue Engineering, Wound Healing, Others.
  • By Region: The market for rapid self-healing gel is anticipated to be dominated by North America over the course of the forecast period due to the increased prevalence of chronic wounds. For instance, according to Ecronicon, millions of Americans experience pressure ulcers every year. This is anticipated to fuel the market for self-healing gel to grow quickly in North America.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1 Research data source
    • 2.1.1 Secondary data
    • 2.1.2 Primary data
    • 2.1.3 SPER's internal database
    • 2.1.4 Premium insight from KOL's
  • 2.2 Market size estimation
    • 2.2.1 Top-down and Bottom-up approach
  • 2.3 Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1 Drivers
    • 4.1.2 Restraints
    • 4.1.3 Opportunities
    • 4.1.4 Challenges
  • 4.2. COVID-19 Impacts of the Global Rapid Self-Healing Gel Market

5. Market variables and outlook

  • 5.1. SWOT analysis
    • 5.1.1 Strengths
    • 5.1.2 Weaknesses
    • 5.1.3 Opportunities
    • 5.1.4 Threats
  • 5.2. PESTEL analysis
    • 5.2.1 Political landscape
    • 5.2.2 Economic landscape
    • 5.2.3 Social landscape
    • 5.2.4 Technological landscape
    • 5.2.5 Environmental landscape
    • 5.2.6 Legal landscape
  • 5.3. PORTER'S five forces analysis
    • 5.3.1 Bargaining power of suppliers
    • 5.3.2 Bargaining power of Buyers
    • 5.3.3 Threat of Substitute
    • 5.3.4 Threat of new entrant
    • 5.3.5 Competitive rivalry
  • 5.4. Heat map analysis

6. Competitive Landscape

  • 6.1 Global Rapid Self-Healing Gel Manufacturing Base Distribution, Sales Area, Product Type
  • 6.2 Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Rapid Self-Healing Gel Market

7. Global Rapid Self-Healing Gel Market, By Crosslinking Type, 2019-2032 (USD Million)

  • 7.1 Chemical
  • 7.2 Physical

8. Global Rapid Self-Healing Gel Market, By Application, 2019-2032 (USD Million)

  • 8.1 3D Printing
  • 8.2 Drug Delivery
  • 8.3 Surface Coating
  • 8.4 Tissue Engineering
  • 8.5 Wound Healing
  • 8.6 Others

9. Global Rapid Self-Healing Gel Market, By Region, 2019-2032 (USD Million)

  • 9.1 Global Rapid Self-Healing Gel Size and Market Share by Region (2019-2025)
  • 9.2 Global Rapid Self-Healing Gel Size and Market Share by Region (2026-2032)
  • 9.3 Asia-Pacific
    • 9.3.1 Australia
    • 9.3.2 China
    • 9.3.3 India
    • 9.3.4 Japan
    • 9.3.5 South Korea
    • 9.3.6 Rest of Asia-Pacific
  • 9.4 Europe
    • 9.4.1 France
    • 9.4.2 Germany
    • 9.4.3 Italy
    • 9.4.4 Spain
    • 9.4.5 United Kingdom
    • 9.4.6 Rest of Europe
  • 9.5 Middle East & Africa
    • 9.5.1 Kingdom of Saudi Arabia
    • 9.5.2 United Arab Emirates
    • 9.5.3 Rest of Middle East & Africa
  • 9.6 North America
    • 9.6.1 Canada
    • 9.6.2 Mexico
    • 9.6.3 United States
  • 9.7 Latin America
    • 9.7.1 Argentina
    • 9.7.2 Brazil
    • 9.7.3 Rest of Latin America

10. Company Profiles

  • 10.1 Advanced Medical Solutions Group PLC
    • 10.1.1 Company details
    • 10.1.2 Financial outlook
    • 10.1.3 Product summary
    • 10.1.4 Recent developments
  • 10.2 Alliqua Biomedical
    • 10.2.1 Company details
    • 10.2.2 Financial outlook
    • 10.2.3 Product summary
    • 10.2.4 Recent developments
  • 10.3 Axelgaard
    • 10.3.1 Company details
    • 10.3.2 Financial outlook
    • 10.3.3 Product summary
    • 10.3.4 Recent developments
  • 10.4 Cardinal Health
    • 10.4.1 Company details
    • 10.4.2 Financial outlook
    • 10.4.3 Product summary
    • 10.4.4 Recent developments
  • 10.5 Contura International
    • 10.5.1 Company details
    • 10.5.2 Financial outlook
    • 10.5.3 Product summary
    • 10.5.4 Recent developments
  • 10.6 Cytogel Pharma
    • 10.6.1 Company details
    • 10.6.2 Financial outlook
    • 10.6.3 Product summary
    • 10.6.4 Recent developments
  • 10.7 Hydromer Inc.
    • 10.7.1 Company details
    • 10.7.2 Financial outlook
    • 10.7.3 Product summary
    • 10.7.4 Recent developments
  • 10.8 Katecho Inc.
    • 10.8.1 Company details
    • 10.8.2 Financial outlook
    • 10.8.3 Product summary
    • 10.8.4 Recent developments
  • 10.9 R&D Medical Products Inc.
    • 10.9.1 Company details
    • 10.9.2 Financial outlook
    • 10.9.3 Product summary
    • 10.9.4 Recent developments
  • 10.10 Scapa Healthcare
    • 10.10.1 Company details
    • 10.10.2 Financial outlook
    • 10.10.3 Product summary
    • 10.10.4 Recent developments

11. List of Abbreviations

12. Reference Links

13. Conclusion

14. Research Scope